MECHANISMS OF DISEASE
N Engl J Med, Vol. 345, No. 23
·
December 6, 2001
·
www.nejm.org
·
1691
portance of aldosterone in potassium homeostasis ismost evident in patients with aldosterone insufficien-cy (Addison’s disease), in whom hyperkalemia is com-mon and can be reversed by treatment with a min-eralocorticoid.
16
Further evidence of the importance of potassiumas a stimulus to aldosterone production comes fromstudies in genetically manipulated mice that do notexpress the angiotensin precursor angiotensinogenand therefore have little or no angiotensin II.
17
Inthese animals, dietary sodium deprivation causes hy-perkalemia, which, in turn, increases aldosterone se-cretion, thereby stimulating the reabsorption of saltand water and maintaining extracellular fluid volume.Restriction of both dietary sodium and potassiumleads to hypotension and death in these animals.In addition to their individual effects on salt and water homeostasis, angiotensin II and aldosteronehave other endocrine actions relevant to the mainte-nance of circulatory homeostasis. They contribute tothe coagulation of blood, in part through the in-creased production of plasminogen-activator inhibitortype 1 and the aggregation and activation of plateletsat sites of bleeding
18
; they constrict systemic arteriolesto preserve arterial pressure in the face of contrac-tion of the intravascular volume
13
; and they stimu-late thirst.
10
Angiotensin II and aldosterone are also involvedin regulating inflammatory and reparative processesthat follow tissue injury.
19,20
In this capacity, they stim-ulate cytokine production, inflammatory-cell adhesion,and chemotaxis; activate macrophages at sites of re-pair
21
; and stimulate the growth of fibroblasts and thesynthesis of type I and III fibrillar collagens, whichgovern the formation of scar tissue.
22
A substance produced by cells within a tissue canexert actions on the same or different cells; these ef-fects are known, respectively, as autocrine and para-crine properties. Recent studies have demonstratedthe presence of aldosterone synthase messenger RNA (mRNA) and its activity together with aldosteroneproduction by endothelial and vascular smooth-mus-cle cells in the heart and blood vessels (Fig. 2).
24-26
Once considered the sole province of the zona glom-erulosa of the adrenal glands because of the key en-zymes involved in its steroidogenesis, the productionof aldosterone by the heart is regulated by angioten-sin II and by modifications in dietary sodium andpotassium. The physiologic importance of locally pro-duced aldosterone is not known, but early findingssuggest that it may contribute to tissue repair aftermyocardial infarction.
27
ALDOSTERONE AND THE PATHOPHYSIOLOGY OF CONGESTIVE HEART FAILURE
Some 60 years ago, both urine and plasma frompatients with congestive heart failure were found tocontain a substance with sodium-retaining activity
28
;this discovery drew attention to the role of the kidney in the pathogenesis of congestive heart failure. It soonbecame evident that the initial stages of heart failureinvolve an expansion of intravascular volume and weight gain that averts volume depletion when relent-less salt and water retention produces extravascular volume expansion (e.g., edema). Subsequently, stud-ies of renal hemodynamics revealed marked reduc-tions in renal blood flow with a less severe decline inglomerular filtration and a preserved or even increasedfiltration fraction.
29-32
The retention of sodium is ev-ident not only in urine but also in feces, sweat, andsaliva, indicating a widespread avidity for sodium. Thesalt-active substance mediating many of these changes was initially named electrocortin, but because of its18-aldehyde steroid structure and adrenal origin it waslater renamed aldosterone.
33
In heart failure, the pres-ence of increased amounts of aldosterone in urine andplasma correlates with the retention of sodium and water at renal and extrarenal sites.In normal subjects whose diet contains a normalamount of sodium, the aldosterone secretion rate is100 to 175 µg (277 to 485 nmol) per day; in pa-tients with congestive heart failure, the aldosteronesecretion rate may be as high as 400 to 500 µg(1100 to 1400 nmol) per day.
34
Values for plasma al-dosterone are in the range of 5 to 15 ng per deciliter(139 to 416 pmol per liter) in normal subjects whosesodium intake is normal and may reach 300 ng perdeciliter (8322 pmol per liter) in patients with con-gestive heart failure — a concentration similar to thatin normal subjects whose sodium intake is severely restricted.
35
Aldosterone secretion in patients withcongestive heart failure is regulated by several majorstimuli. These include angiotensin II and elevationsin serum potassium concentrations. In normal sub- jects, corticotropin is thought to play a short-lived,permissive role in stimulating aldosterone production.However, in patients with congestive heart failure,plasma corticotropin concentrations may be chronical-ly increased, resulting in high plasma cortisol concen-trations and contributing to the increase in aldoste-rone secretion.
36
Minor stimuli, which may take onadditional importance in patients with congestive heartfailure, include circulating catecholamines, endothe-lins, and arginine vasopressin.Decreased metabolic clearance of aldosterone by the liver further contributes to increased plasma con-centrations of aldosterone in patients with congestiveheart failure. In normal subjects, hepatic aldosteroneclearance is complete within one passage through theliver, so that little or no aldosterone is found in he-patic venous plasma. Because of the reduced hepaticperfusion in patients with congestive heart failure,aldosterone clearance is also reduced; this problemis exacerbated by upright posture and ambulation.This reduction can account for a severalfold increase
Downloaded from www.nejm.org on March 29, 2007 . Copyright © 2001 Massachusetts Medical Society. All rights reserved.
Leave a Comment